Clinical Trial Update: Semaglutide and Vascular Regeneration [Phase 4]

View source ↗

Summary

Phase 4 trial update investigating semaglutide for vascular regeneration in patients with atherosclerosis and cardiovascular diseases, with associated condition…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis
• Cardiovascular Diseases
• Obesity
• Type 2 Diabetes Mellitus

Drugs mentioned

• semaglutide (semaglutide)

Snippet

Sponsor: Canadian Medical and Surgical Knowledge Translation Research Group | Conditions: Atherosclerosis, Cardiovascular Diseases | Phase 4 | Status: UNKNOWN